E4orf4, a Novel Adenovirus Death Factor That Induces p53-independent Apoptosis by a Pathway That Is Not Inhibited by zVAD-fmk by Lavoie, Josée N. et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/98/02/637/9 $2.00
The Journal of Cell Biology, Volume 140, Number 3, February 9, 1998 637–645
http://www.jcb.org 637
 
E4orf4, a Novel Adenovirus Death Factor That Induces
p53-independent Apoptosis by a Pathway
That Is Not Inhibited by zVAD-fmk
 
Josée N. Lavoie, M. Nguyen, R.C. Marcellus, P.E. Branton, and G.C. Shore
 
Department of Biochemistry, McGill University, Montreal, Quebec, Canada H3G 1Y6
 
Abstract. 
 
In the absence of E1B, the 289-amino acid 
product of human adenovirus type 5 13S E1A induces 
p53-independent apoptosis by a mechanism that re-
quires viral E4 gene products (Marcellus, R.C., J.C. 
Teodoro, T. Wu, D.E. Brough, G. Ketner, G.C. Shore, 
and P.E. Branton. 1996. 
 
J. Virol.
 
 70:6207–6215) and in-
volves a mechanism that includes activation of caspases 
(Boulakia, C.A., G. Chen, F.W. Ng, J.G. Teodoro, P.E. 
Branton, D.W. Nicholson, G.G. Poirier, and G.C. 
Shore. 1996. 
 
Oncogene.
 
 12:529–535). Here, we show 
that one of the E4 products, E4orf4, is highly toxic 
upon expression in rodent cells regardless of the p53 
status, and that this cytotoxicity is significantly over-
 
come by coexpression with either Bcl-2 or Bcl-X
 
l
 
. Con-
ditional expression of E4orf4 induces a cell death pro-
cess that is characterized by apoptotic hallmark 
features, such as externalization of phosphatidylserine, 
loss of mitochondrial membrane potential, cytoplasmic 
vacuolation, condensation of chromatin, and internu-
cleosomal DNA degradation. However, the wide-spec-
trum inhibitor of caspases, tetrapeptide zVAD-fmk, 
does not affect any of these apoptogenic manifesta-
tions, and does not alter the kinetics of E4orf4-induced 
cell death. Moreover, E4orf4 expression does not result 
in activation of the downstream effector caspase com-
mon to most apoptosis-inducing events, caspase-3 
(CPP32). We conclude, therefore, that in the absence of 
E1A, E4orf4 is sufficient by itself to trigger a p53-inde-
pendent apoptosis pathway that may operate indepen-
dently of the known zVAD-inhibitable caspases, and 
that may involve an as yet uncharacterized mechanism.
 
T
 
issue
 
 homeostasis is maintained by a tight balance
between cellular proliferation and cell death pro-
cesses such as apoptosis. Apoptosis is a cell suicide
mechanism culminating in an autolytic cellular degrada-
tion that can be triggered by a wide range of stimuli, such
as viral infection (White and Gooding, 1994; Teodoro and
Branton, 1997), growth factor withdrawal (Evan et al.,
1992; Rao et al., 1992; Wagner et al., 1994; Lin and Benchi-
mol, 1995; Sakamuro et al., 1995), TNF-
 
a
 
 and Fas ligand
(for review see Nagata, 1997), and DNA damage after ei-
ther irradiation (Clarke et al., 1993; Lowe et al., 1993
 
b
 
;
Strasser et al., 1994; Han et al., 1995), or treatment with
chemotherapeutic drugs (Lowe et al., 1993
 
a
 
). Apoptotic
cell death may occur in either a p53-dependent or -inde-
pendent manner (for review see Liebermann et al., 1995).
The role of p53 as a general tumor suppressor gene is well
established, and its ability to function as a sequence-spe-
cific transcription factor appears to be directly linked to its
role in G1-arrest of the cell cycle in response to detrimen-
tal conditions (Bates and Vousden, 1996). The mechanism
by which p53 regulates induction of apoptosis, however,
remains unclear, but may rely on the ability of p53 to con-
trol expression of proapoptotic inducers such as Bax (Reed,
1997). The molecular determinants of p53-independent
apoptotic responses remain poorly understood.
Although the initial triggering phase of apoptosis may
take several routes, in most cases the execution phase of
this process converges on a common pathway character-
ized by activation of the caspase family of interleukin-
1
 
b
 
–convertase enzyme (ICE)
 
1
 
-like cysteine proteases (Olt-
vai and Korsmeyer, 1994; Steller, 1995; Chinnaiyan and
Dixit, 1996; Fraser and Evan, 1996). Additionally, how-
ever, recent evidence suggests that other pathways, which
do not rely on activation of the known caspases, can also lead
to cell death and manifestation of the morphological fea-
tures of apoptosis (Xiang et al., 1996; Boise and Thompson,
1997). In both cases, irreversible commitment to cell death
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may involve a loss of the mitochondrial membrane poten-
tial (
 
Dc
 
m) through opening of the permeability transition
pore complex (Kroemer et al., 1995; Petit et al., 1995; Zam-
zami et al., 1995
 
a
 
,
 
b
 
; Castedo et al., 1996; Zamzami et al.,
1996; Kroemer, 1997). Regardless of the biochemical
transformations leading to apoptosis, however, the final
phase — the degradation phase — is usually characterized
by typical morphological changes, including plasma mem-
brane blebbing, cytoplasmic boiling and vacuolation, chro-
matin condensation, internucleosomal cleavage of DNA,
cell shrinkage, and fragmentation of the cell into mem-
brane-bound apoptotic bodies that are ultimately engulfed
by other cells (Wyllie, 1980). Not surprisingly, both the ini-
tiation and execution of apoptosis are tightly regulated.
One element of this control is provided by a family of pro-
teins related to Bcl-2, which act as general suppressors of
apoptosis in many contexts, including those leading to p53-
dependent or -independent death (for review see Farrow
and Brown, 1996; Yang and Korsmeyer, 1996).
Adenoviruses have provided important model systems
to study the regulation of DNA synthesis, cell prolifera-
tion, transformation, and apoptosis (Dyson and Harlow,
1992; Moran, 1993; White and Gooding, 1994; Teodoro
and Branton, 1997). The products of early region 1A (E1A
13S and E1A 12S) are the triggers of these cellular effects,
determined by the context in which E1A genes operate. In
the presence of E1B products, for example, the cytotoxic
consequences of E1A expression are blocked, allowing its
growth-promoting properties to be realized (White et al.,
1991; Rao et al., 1992). E1A produces two major mRNAs
of 13S and 12S that encode proteins of 289 and 243 resi-
dues, respectively, and that are identical except for a cen-
tral conserved region, termed CR3, in the 289-residue
product that transactivates expression of other early viral
units (E2, E3, E4; Kimelman et al., 1985). p53 is required
for E1A-induced apoptosis in cells infected by an E1B-
defective Ad5 mutant expressing the 12S E1A mRNA
(Debbas and White, 1993; Lowe and Ruley, 1993; Lowe et
al., 1994; Teodoro et al., 1995; Querido et al., 1997). How-
ever, the alternatively spliced E1A 13S transcript can also
induce apoptosis independently of p53 and appears to rely
on CR3 and additional early viral genes to do so (Teodoro
et al., 1995). Identification of E4 as the requisite early re-
gion providing these cooperating transcripts has come
from mapping experiments conducted in p53-null SAOS-2
cells infected with various mutant viruses (Marcellus et al.,
1996). More recent studies suggest the contribution of the
E4orf4 protein and possibly, E4orf6
 
2
 
. The ability of E4
proteins to contribute to viral cytotoxicity may relate to vi-
ral particle transmission during infection, in which accu-
mulation of progeny virus inside apoptotic bodies permits
the spreading of the virus to neighboring cells while evading
host immune surveillance (Teodoro and Branton, 1997).
In the present study, we report that one of the E4 aden-
oviral proteins, E4orf4, is sufficient by itself to induce p53-
independent cell death. Conditional expression of this 14-kD
product in rodent cells triggers an apoptotic pathway that
may involve a novel signaling event. In contrast to induc-
tion of apoptosis that involves E1A and E1A-dependent
 
activation of caspase-3 (Boulakia et al., 1996; Sabbatini et al.,
1997), we detect no involvement of the zVAD–fmk-inhib-
itable caspases in the mechanism of apoptosis caused by
the solitary delivery of Ad2 E4orf4.
 
Materials and Methods
 
Cell Culture and Inducible Expression System
 
CHO fibroblasts, CHO LR73, and p53-null mouse embryo fibroblasts,
HyA4 (Lowe et al., 1994), were maintained in 
 
a
 
MEM supplemented with
10% fetal bovine serum and streptomycin sulfate/penicillin (100 U/ml).
Cells were grown in a humidified 5% CO
 
2
 
 atmosphere at 37
 
8
 
C. To estab-
lish the CHO-rtTA-orf4 cell lines, the reverse tetracycline (rtTA) transac-
tivator plasmid (pUHD17-1) was first cotransfected in CHO cells together
with the pCDNA3 vector encoding the neomycin resistance gene. Stable
transfectants were isolated after a 15-d selection period in the presence of
G-418 (800 
 
m
 
g/ml), and screened on the basis of their responsivness to
doxycycline, as previously described (Gossen et al., 1995). Clone CHO-13
was selected for its low basal and highly doxycycline-induced transactiva-
tion activity. A hemagglutinin (HA) epitope tag (Chen et al., 1996) was
placed at the 5
 
9
 
 end of Ad2 E4orf4 coding sequence by standard PCR us-
ing the sense and antisense oligos, 5
 
9
 
 GGGGTACC ATG GCG TAC
CCA TAC GAT GTT CCA GAT TAC GCT ATG GTT CTT CCA GCT
CTT CC 3
 
9
 
 and 5
 
9
 
 CTA CTG TAC GGA GTG CGCC 3
 
9
 
, respectively.
The resulting DNA fragment was sequenced and then cloned into the
SacII/XbaI sites of PUHD10-3, containing the hCMV minimal promoter
with heptamerized tetoperators (Gossen and Bujard, 1992). Studies con-
firmed that the HA tag did not interfere with the ability of orf4 to induce
cytotoxicity. HA-orf4/PUHD10-3 plasmid was cotransfected together
with pJK-puro, encoding the puromycin resistance gene into CHO-13 in-
ducible clonal cell line. Stable transfectants were isolated after a 15-d se-
lection period in the presence of puromycin (2 
 
m
 
g/ml) and then screened
for induction of orf4 protein after addition of doxycycline at 1 
 
m
 
g/ml
(Sigma Chemical Co., St. Louis, MO). Two clones, named CHO-orf4-7
and CHO-orf4-4, were selected on the basis of their high doxycycline-
induced HA-orf4 protein expression. The percentage of cells expressing
HA-orf4 was evaluated after induction in the presence of doxycycline for
varying periods, by immunolocalization studies (50% for clone CHO-orf4-7,
and 38% for clone CHO-orf4-4, respectively).
 
Transient Transfection and Luciferase Assay
 
CHO LR73 and HyA4 cells were seeded at a density of 150,000 cells per
well in 24-well plates and then cotransfected by the calcium phosphate
method with 0.2 
 
m
 
g of the reporter plasmid pRSV-luc, together with 2.0 
 
m
 
g
of expression vector containing either E4orf4 or E4orf2 coding sequences
(Öhman et al., 1993) cloned into pCDNA3 as described
 
2
 
, and 3.8 
 
m
 
g of
sheared salmon sperm DNA, or 3.8 
 
m
 
g of expression vector containing
Bcl-2 (Nguyen et al., 1994) or Bcl-X
 
l
 
 sequences (Ng et al., 1997). 48–72 h
after transfection, cells were lysed, and then aliquots were assayed for lu-
ciferase activity as previously described (Lavoie et al., 1996
 
a
 
). Data are
representative for at least three independent experiments performed in
duplicate and are expressed as relative luciferase units, which were calcu-
lated relative to the luciferase activity in cells cotransfected with the corre-
sponding empty vectors set to 1 U. For screening of the CHO-rtTA clonal
cell lines, cells were transfected with 0.2 
 
m
 
g of pTRE-luc/pUHD10-3 (Gos-
sen and Bujard, 1992) and 4.8 
 
m
 
g of sheared salmon sperm DNA. 24 h after
transfection, doxycycline was added to the culture medium at 1 
 
m
 
g/ml for
36 h and then the luciferase activity was measured.
 
Cell Viability and DNA Degradation Assay
 
CHO-orf4 cell lines were seeded in 12-well plates and incubated in the
presence of 1 
 
m
 
g/ml doxycycline for various periods of time. Nonadherent
and adherent cells were collected, and then aliquots were mixed with an
equal volume of 0.4% trypan blue (GIBCO BRL, Gaithersburg, MD).
The percentage of cells that picked up the dye was determined and consid-
ered to be dead cells. Data are representative of at least three indepen-
dent culture dishes per time point and these are corrected for the percent-
age of cells expressing orf4 as revealed by immunofluorescence on parallel
cultures induced with doxycycline. Measurement of internucleosomal
DNA cleavage was achieved in CHO-orf4-7 cells incubated in the pres-
 
2. Marcellus, R.C., J.N. Lavoie, D. Boivin, G.C. Shore, and P.E. Branton,
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ence of 1 
 
m
 
g/ml doxycycline or 1.0 
 
m
 
g/ml anti-human Fas antibody (clone
CH-11; Upstate Biotechnology Inc., Lake Placid, NY) for various periods
of time. Where required, zVAD-fmk was added simultaneously with the
apoptotic triggering signal at a final concentration of 50 
 
m
 
M (Enzyme Sys-
tem Products, Dublin, CA). Adherent and nonadherent cells from a 60-mm
Petri dish were collected, washed in PBS, and resuspended gently in 0.5 ml
of lysis buffer (10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 0.2% Triton X-100).
After a 30-min incubation at room temperature, the samples were centri-
fuged at 12,000 rpm for 30 min. 150 
 
m
 
l of 5 M NaCl and 500 
 
m
 
l of 100%
ethanol were added to the supernatant, and DNA was then precipitated
overnight at 
 
2
 
20
 
8
 
C. Samples were centrifuged at 12,000 rpm for 30 min,
and then pellets were resuspended in Tris/EDTA (TE). Extracted nucleic
acids were treated with RNaseA at 37
 
8
 
C for 1 h and then analyzed on 1%
agarose gels stained with ethidium bromide.
 
Immunoblotting and Immunofluorescence Analysis
 
Cells were lysed in SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 2.3%
SDS, 10% glycerol, 5% 
 
b
 
-mercaptoethanol, 0.05% bromphenol blue, 1 mM
phenylmethylsulfonyl fluoride), and then equal amounts of protein from
whole cell lysates were separated by SDS-PAGE in 12–14% acrylamide
gels. Proteins were detected immunologically after electrotransfer onto ni-
trocellulose membranes as described previously (Lavoie et al., 1995). Blots
were developed with either mouse anti-HA HA.11 (BAbCO, Richmond,
CA), rabbit polyclonal CPP32 antibody raised against the recombinant
p17 subunit of CPP32 (Boulakia et al., 1996), provided by D.W. Nicholson
(Merck-Frosst Center for Therapeutic Research, Pointe Claire-Dorval,
Quebec, Canada), or rabbit polyclonal poly(ADP-ribosyl) polymerase
(PARP) antibody 422, raised against the automodification domain of bo-
vine PARP as described (Duriez et al., 1997), provided by G. Poirier
(Centre Hospitalier du l’Université Laval Research Center, Sainte-Foy,
Quebec, Canada). Horseradish peroxidase-linked goat anti–rabbit or
anti–mouse immunoglobulin G (Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA), revealed by the enhanced chemiluminescence de-
tection system (Amersham Corp., Arlington Heights, IL), was used to de-
tect the antigen–antibody complexes. Protein concentrations were mea-
sured using the Bio-Rad (Hercules, CA) assay. For immunolocalization of
HA-orf4, cells were plated on glass coverslips and then incubated in the
presence of doxycycline for various periods of time. Cells were washed in
PBS containing 1 mM MgCl
 
2
 
 and then fixed in 3.7% formaldehyde/PBS
for 20 min. Permeabilization of cells was performed in 0.2% Triton X-100/
PBS for 5 min, and then mouse anti-HA HA.11, followed by Texas red–
conjugated anti–mouse immunoglobulin G (Molecular Probes, Inc., Eu-
gene, OR) were used to detect HA-orf4. The nuclear morphology of cells
was analyzed by staining of DNA with 4
 
9
 
-6-diamidino-2-phenylindole dihy-
drochloride (DAPI; Molecular Probes, Inc.). Annexin V binding assays
were performed by incubating the cells at 37
 
8
 
C in the presence of fluores-
cein-conjugated human annexin V at a final concentration of 0.1 
 
m
 
g/ml for
15 min. Cells were then fixed in binding buffer (10 mM Hepes, NaOH, pH
7.4, 150 mM NaCl, 5 mM KCl, 1 mM MgCl
 
2
 
, 1.8 mM CaCl
 
2
 
, 3.7% formalde-
hyde, 0.1 
 
m
 
g/ml annexin V) for 10 min in the dark and then visualized. Mi-
tochondrial membrane potential was monitored by incubating cells grown
on coverslips in culture medium containing 137 mM KCl to abolish the
plasma membrane potential, and 1 
 
m
 
g/ml tetramethylrhodamine ethyl es-
ter perchlorate (TMRE; Molecular Probes, Inc.) at 37
 
8
 
C for 10 min. Cov-
erslips were rinsed in warm dye-free culture medium containing 137 mM
KCl and then mounted in a living cell chamber made of 0.7-mm-thick rub-
ber containing the same medium, as previously described (Chen, 1989). In
parallel experiments, cells were preincubated in the presence of 10 
 
m
 
M
CCCP at 37
 
8
 
C for 20 min to abolish the mitochondrial membrane poten-
tial before in vivo staining, as a control for the specificity of the dye (data
not shown).
 
Electron Microscopy
 
CHO-orf4-7 cells were incubated in the presence of 1 
 
m
 
g/ml doxycycline
and 50 
 
m
 
M zVAD–fmk for 36 h. Nonadherent and adherent cells were
collected, washed in sucrose buffer, and then fixed with 3% glutaralde-
hyde in 0.1 M cacodylate buffer, pH 7.2–7.4, for 90 min at room tempera-
ture. Postfixation was performed with 1% osmium tetroxide in 0.1 M ca-
codylate buffer for 1 h at 4
 
8
 
C, followed by en bloc staining with 2% uranyl
acetate for 30 min. Samples were dehydrated and embedded in Epon
(Polysciences, Inc., Warington, PA). Thin sections (75-nm) were analyzed
by transmission electron microscopy using an electron microscope (model
410; Philips Electron Optics, Eindhoven, The Netherlands).
 
Results
 
p53-independent E4orf4 Cytotoxicity Can Be 
Significantly Overcome by Coexpression of Bcl-2
Family Members
 
Cytotoxicity assays using a panel of E4-mutated adenovi-
ruses identified E4orf4 as an important contributor to p53-
independent apoptosis triggered by 13S E1A
 
2
 
. To directly
assess the effect of this protein without interference from
other viral products, an indirect measure for E4orf4-
dependent cytotoxicity was established by transiently ex-
Figure 1. (A) Ectopic expression
of E4orf4 triggers a decrease in the
transcription of a luciferase re-
porter, regardless of the p53 status.
p53-null mouse embryo fibroblasts
(HyA4), or wt p531 fibroblasts (CHO
LR73) were cotransfected with
pRSV-luc, together with vectors
containing E4orf4 or E4orf2 se-
quences, or the corresponding empty
vector (EV). 3 d after the transfec-
tion, cells were lysed and then lu-
ciferase expression was measured.
The relative luciferase activity was
calculated relative to the luciferase
expression measured in cells trans-
fected with pRSV-luc and the EV,
set to 1 U. Data are representative
for at least three independent ex-
periments. (B) E4orf4 cytotoxicity
is partially overcome by antiapop-
totic Bcl-2 family members. HyA4 or CHO LR73 cells were cotransfected with pRSV-luc, together with a combination of E4orf4 and
Bcl-2, E4orf4 and BclXl, or E4orf4 and EV in a ratio of 0.2:2.0:4.0 mg of expression plasmids. Luciferase activities were measured 3 d af-
ter transfections and are expressed relative to the luciferase activity measured in cells transfected with pRSV-luc/E4orf4/EV set to 1 U.
Error bars were calculated based on at least three independent experiments. 
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pressing E4orf4 together with a luciferase reporter in p53-
null mouse embryo fibroblasts (HyA4) by standard
cotransfection (Fig. 1 
 
A
 
). By 3 d after transfection, E4orf4
produced an 80% decrease in luciferase activity compared
to luciferase expression measured in cells transfected ei-
ther with the corresponding empty vector or with another
E4 product, E4orf2. Expression of E4orf4 in CHO LR73
cells, which are p53
 
1
 
, also produced a similar decrease in
luciferase activity (Fig. 1 
 
A
 
), suggesting that E4orf4 is po-
tentially cytotoxic regardless of the p53 status.
As a first step to investigate the nature of the E4orf4-
dependent loss of luciferase expression, the transient trans-
fection assays were conducted in the presence of the domi-
nant suppressors of apoptosis, Bcl-2 or Bcl-X
 
l
 
. HyA4 and
CHO LR73 cells were cotransfected with E4orf4, the lu-
ciferase reporter, and either Bcl-2 or Bcl-X
 
l
 
. The results
showed that the presence of Bcl-2 or Bcl-X
 
l
 
 significantly
reversed the decrease in luciferase activity mediated by
expression of E4orf4, as compared to the luciferase activ-
ity measured in cells transfected with E4orf4 and the cor-
responding Bcl-2/Bcl-X
 
l
 
–deleted control vector (Fig. 1 
 
B
 
),
suggesting that E4orf4-dependent loss of luciferase activ-
ity likely resulted from induced cellular apoptosis.
 
Conditional Expression of E4orf4 in Rodent Cells 
Causes a Cell Death Process That Is Characterized by 
Typical Apoptotic Hallmark Features
 
To better characterize E4orf4 cytotoxicity and to determine
whether its expression is sufficient to induce cell death, we
established a rtTA-inducible system in CHO LR73 cells
(CHO-orf4). An HA-tagged version of Ad2 E4orf4 was
used in this system to facilitate the detection of the viral
product. Clonal inducible CHO-orf4 cell lines were iso-
lated as described (refer to Materials and Methods). HA-orf4
protein was induced to a significant level in CHO-orf4-7
cells within 7 h of exposure to doxycycline and increased
further to reach a maximum level of expression per milli-
gram total cell protein at 48 h after treatment (Fig. 2 
 
A
 
).
Induction of HA-orf4 resulted in early cell lifting and a
progressive increase in cell death, with the onset of membrane
permeability to trypan blue occurring at 
 
z
 
16 h after induc-
tion, and reaching 40–50% of the cell population expressing
HA-orf4 within 48 h of doxycycline exposure (Fig. 2 
 
B
 
).
The nuclear morphology of HA-orf4–expressing cells
was analyzed by DNA staining of doxycycline-treated CHO-
orf4-7 using DAPI, combined with immunolocalization of
HA-orf4 in the same cells using anti-HA antibody. DNA
staining of control CHO-orf4-7 cells that did not express
HA-orf4 showed a diffuse staining pattern and a regular
nuclear morphology (Fig. 3 
 
A
 
, 
 
first panel
 
). In contrast, in-
duction of HA-orf4 expression in the same cell line incu-
bated in the presence of doxycycline for 24 h produced
striking changes in the nuclear morphology, as well as in the
whole cell structure. HA-orf4–expressing cells dramatically
shrunk and showed an irregular nuclear morphology, char-
acterized by intense staining of condensed chromatin (Fig.
3 
 
A
 
, 
 
second panel
 
). Fragmentation of the nucleus was also
observed in cells expressing high levels of HA-orf4. These
typical apoptotic features occurred exclusively in the pres-
ence of HA-orf4, since some cells in the population that
had been exposed to doxycycline, and which did not show
expression of the protein, also did not show abnormal
DNA staining (Fig. 3 
 
A
 
, 
 
third panel
 
). Interestingly, immu-
nostaining of HA-orf4 revealed that, although the protein
was diffusively distributed throughout the whole cell, a
stronger staining was detected at the nuclear level, sug-
gesting that HA-orf4 may be preferentially localized in the
nucleus in this cell system (Fig. 3 
 
A
 
, 
 
third panel
 
).
Another important event during apoptosis is the acqui-
sition of plasma membrane changes that allow phagocytes
to recognize and engulf these cells before they rupture.
Figure 2. (A) Time course induction of HA-orf4 expression in
CHO-orf4-7 clonal cell line. An rtTA-inducible system was estab-
lished using an HA-tagged version of Ad2 E4orf4 in CHO LR73
cells, as described in Materials and Methods. CHO-orf4-7 clonal
cells were incubated in the presence of doxycycline at 1 m/ml for
the indicated periods of time. Equal amounts of whole cell lysates
were seperated by SDS-PAGE on a 14% polyacrylamide gel, and
then HA-orf4 was detected by Western blots using an anti-HA
antibody. (B) Time course of E4orf4 killing in CHO-orf4 clones.
Positive cell lines CHO-orf4-4 and CHO-orf4-7, as well as a con-
trol CHO-rtTA cell line, were incubated in the presence of 1 mg/ml
doxycycline. At the indicated periods of time, nonadherent and
adherent cells were harvested, and then equal aliquots of cell sus-
pensions were mixed with an equal volume of trypan blue. The
percent of cell death was calculated from the amount of cells in-
corporating the dye relative to the total amount of cells. Data are
corrected for the total amount of cells expressing HA-orf4 deter-
mined by immunostaining of the protein and are representative
of at least three different Petri dishes. 
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Early redistribution of phosphatidylserine to the outer
plasma membrane leaflet, for example, has been described
as a general feature of apoptosis, regardless of the initiat-
ing stimulus (Martin et al., 1995). Induction of HA-orf4 in
CHO-orf4-7 cells also led to externalization of phosphati-
dylserine. When fluorescein-conjugated annexin V, a phos-
phatidylserine binding protein, was used as a probe to de-
tect the presence of the phospholipid, a dramatic increase
in staining of nonpermeabilized cells was detected after in-
cubation of CHO-orf4-7 cells with doxycycline for 16 h
(Fig. 3 
 
B
 
, 
 
third and fourth panels
 
). In contrast, annexin V
staining was barely detectable in most cells in the absence
of HA-orf4 (Fig. 3 
 
B
 
, 
 
first and second panels
 
). As de-
scribed in other systems, externalization of phosphati-
dylserine occurred soon after HA-orf4 induction and pre-
ceded cellular death.
Finally, isolation of low molecular weight DNA from
CHO-orf4-7 cells incubated with doxycycline for various
periods of time revealed the presence of oligonucleosomal
DNA ladders, which became detectable after 24 h but
reached a significant intensity 64 h after induction of HA-
orf4 (Fig. 3 
 
C
 
). As expected, such apoptotic DNA degra-
dation was observed at relatively late times after HA-orf4
expression, as compared to changes such as DNA conden-
sation and externalization of phosphatidylserine.
 
E4orf4-induced Apoptosis Is Not Inhibited
by zVAD-fmk
 
To initially characterize the signaling pathway implicated in
E4orf4-mediated apoptosis, activation of caspase-3 (CPP32/
apopain/Yama), an ICE-like cysteine protease that has been
shown to perform a central role in many apoptosis systems
(Fernandes-Alnemri et al., 1994; Nicholson et al., 1995;
Tewari et al., 1995; Casciola et al., 1996; Schlegel et al.,
1996), was monitored. CHO-orf4-7 cells were incubated in
the presence of either doxycycline, to induce HA-orf4–
mediated apoptosis, or hygromycin B, to induce apoptosis
(Chen et al., 1995) in the absence of the viral protein. Im-
munoblotting of total cell extracts was performed using an
antibody raised against the recombinant p17 subunit of
caspase-3 (Boulakia et al., 1996), or the 422–anti-PARP anti-
body, which recognizes the full-length PARP and the 85-kD
cleaved product observed after apoptotic stimuli (Duriez
et al., 1997). Processing of procaspase-3 upon an apoptotic
signal yields two subunits of 17 and 12 kD, which assemble
to form the active tetrameric holoenzyme (Nicholson et al.,
1995). Treatment of CHO-orf4-7 cells with hygromycin B
for 48 h triggered processing of procaspase-3, as revealed
by the appearance of the 17-kD subunit, as well as cleav-
age of PARP, a substrate for active caspase-3 (Nicholson
et al., 1995; Tewari et al., 1995) (Fig. 4). In contrast, no
Figure 3.  Induction of
E4orf4 expression triggers an
apoptotic  cell death process.
(A) HA-orf4 expression in-
duced DNA condensation.
Cells grown on glass cover-
slips were incubated with 1
mg/ml doxycycline for 24 h.
Fluorescent detection of HA-orf4–positive cells was performed using an anti-HA followed by a flu-
orescent-labeled anti-mouse, and then DNA was stained with DAPI. Double staining of the speci-
men revealed DNA condensation in HA-orf4–expressing cells (second and third panels) as com-
pared to normal nuclear morphology in the same cells, in absence of HA-orf4 (2dox, first panel).
(B) E4orf4 expression induced externalization of phosphatidylserine. CHO-orf4-7 cells were
grown on glass coverslips in the presence or absence of 1 mg/ml doxycycline for 16 h. Staining of
phosphatidylserine was performed in living unpermeabilized cells using fluorescein-conjugated an-
nexin V. First and second panels show the absence of annexin V binding in untreated cells, as com-
pared to the staining observed after induction of HA-orf4 (third and fourth panels). (C) Time-course
induction of internucleosomal DNA degradation in CHO-orf4–expressing cells. HA-orf4 expres-
sion was induced in CHO-orf4-7 cells incubated with doxycycline for the indicated periods of time.
Analysis of extracted nucleic acids on agarose gels showed the appearance of typical DNA ladders
upon induction of HA-orf4. 
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17-kD band was detectable in CHO-orf4-7 after a 48-h in-
cubation in the presence of doxycycline (Fig. 4), when
HA-orf4 expression was maximal (Fig. 2 
 
A). Consistent
with this, no PARP cleavage was observed. A detailed ki-
netic analysis performed at various times after induction
of HA-orf4 failed to reveal at any time processing of pro-
caspase-3 or cleavage of PARP in cells undergoing HA-
orf4–mediated cell death (data not shown).
The requirement of caspase activities for orf4-induced
apoptosis was further assessed by examining the effect of
zVAD-fmk on orf4-mediated apoptosis. zVAD-fmk is a cell-
permeable inhibitor of all caspases examined to date and
blocks or retards cellular apoptosis that is caused by a di-
verse set of signals (Polverino and Patterson, 1997) includ-
ing cell death in response to ligation of Fas (Slee et al.,
1996; Xiang et al., 1996). As expected therefore, zVAD-
fmk had an inhibitory effect on the appearance oligonu-
cleosomal ladders in CHO-orf4-7 cells that had not re-
ceived doxycycline, but rather had been treated with Fas
antibody for as long as 64 h (Fig. 5 A). When present dur-
ing induction of E4orf4 in these cells, however, no such in-
hibition by zVAD-fmk was observed (Fig. 5 A). Similarly,
zVAD-fmk did not prevent the typical ultrastructural
changes in cells undergoing HA-orf4–mediated apoptosis.
Analysis of doxycycline-treated CHO-orf4-7 cells by elec-
tron microscopy showed that chromatin condensation and
cytoplasmic vacuolation still occurred in the presence of
the protease inhibitor (Fig. 5 B), whereas these morpho-
logical changes were inhibited in Fas-treated cells in the
presence of the inhibitor (data not shown). To exclude the
possibility of a transient protective effect of zVAD-fmk at
earlier times, as suggested in a recent report (Sabbatini et
al., 1997), early changes in nuclear morphology, detectable
by DAPI staining of DNA, were analyzed after incubation
of CHO-orf4-7 cells with doxycycline for 16 h. Although
zVAD-fmk prevented the appearance of apoptotic figures
in a population of cells treated with hygromycin B during
16 h, no protective effect was observed in cells expressing
HA-orf4 (Fig. 5 C). Also, zVAD-fmk had no effect on the
time-course induction of orf4-mediated cell death, whereas
the kinetics of hygromycin B–induced death were signifi-
cantly delayed (Fig. 5 D).
E4orf4-mediated Cell Death Is Accompanied By a Loss 
in Mitochondrial Membrane Potential
A common biochemical transformation in cells undergo-
ing apoptosis is a loss in the mitochondrial electrochemical
potential as a consequence of permeability transitions at
the inner membrane of the organelle (Kroemer et al., 1995;
Zamzami et al., 1996). Moreover, these mitochondrial tran-
sitions, which can be assayed in whole cells using poten-
tial-sensitive dyes, occur in cells undergoing apoptosis in
the absence of caspase activation (Xiang et al., 1996). Thus,
mitochondria were stained in living CHO-orf4-7 cells using
a derivative of rhodamine, a fluorescent lipophilic cation
that accumulates selectively in mitochondria in the pres-
ence of an intact mitochondrial membrane potential, in ac-
cordance with the Nernst potential (Chen, 1989). The re-
sults showed that, in the absence of HA-orf4 expression,
dye accumulated in mitochondria of all cells, leading to a
typical granular staining surrounding the nucleus (Fig. 6,
Control). However, induction of HA-orf4 expression trig-
gered a dramatic decrease in staining over the same incu-
bation period with the dye, an effect that was maintained
in the presence of zVAD-fmk. The residual staining was
rather diffuse and delocalized, similar to that observed af-
ter treatment of these cells with hygromycin B (Fig. 6).
Discussion
Until recently, studies on oncogenesis have focused on the
regulation of signal transduction pathways leading to cell
proliferation (Stanbridge and Nowell, 1990; Lavoie et al.,
1996b). However, the requirement of negative control, in-
cluding growth arrest and programmed cell death, in the
course of cellular maturation/differentiation and mainte-
nance of appropriate cell numbers, is now recognized as an
equally important process (Cohen, 1991; Levine, 1993; Olt-
vai and Korsmeyer, 1994; Thompson, 1995). Evidence has
accumulated that defects in both the genes that regulate
cell growth and the genes that control cell death can coop-
erate in neoplasia and its progression towards more malig-
nant phenotypes. Considering that p53 remains the most
frequent target for genetic alterations identified in human
cancers, understanding the molecular basis of p53-inde-
pendent apoptosis is thus essential. Because E1A can in-
duce both p53-dependent and -independent apoptosis, it
provides an interesting model to study the various regula-
tory pathways implicated in triggering the commitment of
a cell to apoptosis, as well as the players responsible for
the execution of the processes. Induction of p53-indepen-
dent cell death induced by the E1A 13S product relies at
least in part on the ability of the protein to transactivate
one or more of the viral E4 products (Marcellus et al.,
1996), suggesting that E4 proteins, individually or in coop-
eration, contribute to the death process. Additional map-
ping studies2 identified E4orf4 as one of the candidate E4
products. Here, we have documented the ability of E4orf4
to independently induce cytotoxicity by a mechanism that
involves many of the classical hallmark features of apopto-
sis. However, the results obtained suggest that E4orf4-
mediated apoptosis may not require activation of the
known caspases. This latter conclusion is based on the fail-
ure to detect processing of procaspase-3, an event com-
Figure 4. Absence of procaspase-3 processing and PARP cleav-
age in cells undergoing E4orf4-mediated apoptosis. CHO-orf4-7
cells were incubated in the presence of 1 mg/ml doxycycline, or
400 mg/ml hygromycin B, for 48 h. Equal amounts of whole cell
lysates were seperated by SDS-PAGE on a 12% polyacrylamide gel,
and pro-CPP32 (p32), as well as the cleaved subunit p17, were de-
tected by Western blot using an antibody raised against the re-
combinant p17 subunit of CPP32. PARP was detected in the
same extracts by immunoblotting with anti-PARP antibody 422.Lavoie et al. p53-independent Apoptosis Induced by Ad E4orf4 643
mon to many apoptosis signaling pathways (Fernandes-
Alnemri et al., 1994; Nicholson et al., 1995; Schlegel et al.,
1996; Tewari et al., 1995; Casciola et al., 1996), and more
importantly, by the failure of the wide spectrum caspase
inhibitor, zVAD-fmk, to block E4orf4 cytotoxicity in cell
cultures. Furthermore, the kinetics of orf4-induced apop-
tosis were unaffected by zVAD-fmk, whereas apoptosis
induced by hygromycin B was delayed, implying that the
failure of zVAD-fmk to influence orf4-mediated killing was
not because of ineffective inhibition of caspases. Due to the
absence of a P4 determinant, zVAD-fmk has been designed
to inhibit all ICE-like caspases (Zhu et al., 1995). It cannot
be ruled out that an as yet unidentified caspase is induced
by orf4 and must have unusual properties. p53-indepen-
dent apoptosis induced by the 13S E1A product in the
context of a virus that contains an intact E4 region is asso-
ciated with processing and activation of procaspase-3 (Bou-
lakia et al., 1996), suggesting either that this E1A product
contributes to more than one apoptosis signaling event within
the p532/2 context, or that additional E4 genes are required.
Whatever the case, our results suggest a model in which the
13S E1A product is capable of inducing p53-independent
apoptosis because one or more E4 products, including
E4orf4, contributes to an apoptosis-inducing function that
would otherwise require a cellular p53 downstream event.
The proapoptotic member of the Bcl-2 family, Bax (Oltvai
and Korsmeyer, 1994), exhibits several of the properties
that might be expected of such a p53 downstream event
that can be substituted by E4orf4. First, evidence has been
obtained that BAX is a target of p53 transcriptional activa-
tion (Miyashita et al., 1994; Selvakumaran et al., 1994; Mi-
yashita and Reed, 1995). Second, although Bax expression
induces activation of procaspase-3, it is also capable of
inducing all of the apoptotic manifestations that are also ob-
served for E4orf4 when expressed in the presence of zVAD-
fmk (Xiang et al., 1996). Finally, Bcl-Xl, a heterodimer-
izing partner of Bax, is also capable of functioning at a step
downstream of the caspases, protecting cells against the
loss of mitochondrial membrane potential. This is consis-
tent with our finding that Bcl-2/Bcl-Xl protects cells against
Figure 5. zVAD-fmk does
not prevent E4orf4-induced
apoptosis. (A) Internucleoso-
mal DNA degradation was
analyzed in doxycycline-
treated CHO-orf4-cells, in the
presence or absence of 50 mM
zVAD-fmk, as compared to
cells treated with 1 mg/ml Fas
Ab in the same conditions.
Analysis of the extracted nu-
cleic acids showed that
whereas the presence of
zVAD-fmk significantly at-
tenuated the DNA ladders
induced by treatment with
Fas Ab, it did not prevent
E4orf4-mediated DNA deg-
radation. (B) The ultrastruc-
ture of CHO-orf4-7 cells was
analyzed by electron micros-
copy in untreated cells (first
panel), as compared to cells
incubated with doxycycline
for 36 h, in the presence
(third panel) or absence (sec-
ond panel) of 50 mM zVAD-
fmk. Condensation of the
chromatin as well as cyto-
plasmic vacuolation is still
detectable in the presence of
the ICE-like protease inhibi-
tor. (C) CHO-orf4-7 cells
grown on glass coverslips
were incubated in the pres-
ence of either 1 mg/ml doxycycline, or 400 mg/ml hygromycine B for 16 h, in the presence or absence of 50 mM zVAD-fmk. Immunode-
tection of HA-orf4 and DNA staining was then performed by double immunofluorescence. Cells were counted, and the percentage of
cells arboring an abnormal nuclear morphology is shown. At least 300 cells were counted for each condition, and data related to doxycy-
cline-treated cells were corrected for the number of cells expressing HA-orf4. (D) CHO-orf4-7 cells were incubated in the presence of
either 1 mg/ml doxycycline, or 400 mg/ml hygromycine B for 16 h, in the presence or absence of 50 mM zVAD-fmk. At the indicated times,
nonadherent and adherent cells were harvested and pooled, and then equal aliquots of cell suspension were mixed with an equal volume
of trypan blue. The percent cell death was calculated from the amount of cells incorporating the dye relative to the total amount of cells.
Data are corrected for the total amount of cells expressing HA-orf4 determined by immunostaining of the protein and are representa-
tive of at least three different Petri dishes.The Journal of Cell Biology, Volume 140, 1998 644
E4orf4 cytotoxicity. It remains to be determined, however,
if E4orf4 is simply acting like a partially functional ana-
logue of Bax. Sequence analysis of E4orf4, for example,
does not reveal the presence of strong similarities to the
structural hallmarks of the Bax family, notably the BH3
domain (Yang and Korsmeyer, 1996). The one known
function of E4orf4 relates to its ability to bind the hetero-
trimeric form of protein phosphatase (PP)2A and to in-
crease the activity of the holoenzyme (Kleinberger and
Shenk, 1993), but whether or not this increase in PP2A is
sufficient to explain the apoptosis inducing properties of
E4orf4 is not yet known. It is additionally relevant, how-
ever, that regulators of the Bcl-2 family setpoint are sub-
ject to phosphorylation/dephosphorylation events. These
include Bad (Zha et al., 1996), as well as Bcl-2 itself (Hal-
dar et al., 1995; Strack et al., 1996; Chang et al., 1997). An-
other possibility, therefore, is that E4orf4 links PP2A to
these potential targets at sites where the Bcl-2 family pro-
teins function downstream of the caspases (Boise and
Thompson, 1997). Finally, it may be that E4orf4 is multi-
functional, despite its relatively small size (14-kD), and
that its role in apoptosis is different than its effect on
PP2A. Future characterization of E4orf4 interaction(s)
with cellular proteins should provide insights into the sig-
naling pathways involved in mediating E4orf4 p53–inde-
pendent apoptosis.
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